They found that AML cells expressing IDO (possibly by inducing FoxP3 expression) could convert normal CD4+CD25− T cells into CD4+CD25+ Tregs, which was completely abolished in vitro by inhibiting IDO via 1-methyl-tryptophan (a competitive inhibitor of IDO) [31]. This evidence concerns the gene CD4 and acute myeloid leukemia.